Chronological

 

 

2016

Meckel M, Kubíček V, Hermann P, Miederer M, Rösch
FA DOTA based bisphosphonate with an albumin binding moiety for delayed body clearance for bone targeting.
Nucl Med Biol. 2016 Nov;43(11):670-678.
Doi: 10.1016/j.nucmedbio.2016.07.009.

Perez-Malo M, Eppard E, Rösch F
Improves efficacy of synthesis ofM(III)-labeled radiopharmaceuticals in mixtures of aqueous solution and non-aqueous solvents
Angewante

De la Fuente A, Eppard E, Mohr N, Allmeroth M, Zentel R, Rösch F
Labeling of HPMA-based polymer conjugates with metallic radionuclides for theranostic applications (2016)

Eppard E, Zhernosekov KP, Filosofov DV, Rösch F.
68Ga radiolabelling in aqueous sulutions utilizing cation exchange based post-processing for clinical application.
Nature Protocolls (2016)

Meckel M, Bergmann R, Miederer M, Rösch F.
Bone targeting compounds for radiotherapy and imaging: *Me(III)-DOTA conjugates ofbisphosphonic acid, pamidronic acid and zeledronic acid.
EJNMMI Radiopharmacy and Chemistry 2016 1:14
DOI: 10.1186/s41181-016-0017-1

Spang P, Herrmann C, Rösch F.
Bifunctional gallium-68 chelators: Past, present and future
Seminars in Nulear Medicine 46/5 (2016) 373-94,
Doi: 10.1053/j.semnuclmed.2016.04.003

Passah A, Tripathi M, Ballal S, Yadav MP, Kumar R, Rösch F, Meckel M, Chkraborty PS, Bal C.
Evaluation of bone seeking novel radiotracer 68Ga-NO2AP-bisphosphonate for the detection of skeletal metatstasesin carcinoma breast
EJNMMI (2016)

Wagener C, Moderegger D, Allmeroth M, Reibel A, Zentel R, Thews O, Rösch F.
Long-term biodistribution study of HPMA-ran-LMA copolymers in vivo by means of I-131-labeling
Nucl Med Biol (2016)

Valery Radchenko, Dmitry V. Filosofov, Jakhongir Dadakhanov, Dimitar V. Karaivanov, Atanaska Marinova, Ayagoz Baimukhanova
and Frank Rösch*

Direct flow seperation strategy, to isolate no-carrier-added 90Nb from irradiated Mo or Zr targets.
Radiochim. Acta 2016,
DOI 10.1515/ract-2015-2543

Kerdjoudj R, Pniok M, Alliot C, Kubíček V, Havlíčková J, Rösch F, Hermann P, Huclier-Markai S.
Scandium(iii) complexes of monophosphorus acid DOTA analogues: a thermodynamic and radiolabelling study with 44Sc from cyclotron and from a 44Ti/44Sc generator.
Dalton Trans. 2016 Jan 19;45(4):1398-409

Fritz T, Voigt M, Worm M, Negwer I, Müller S, Kettenbach K, Ross T, Rösch F, Koynov K, Frey H, Helm M.
Orthogonal click conjugation to the liposomal surface reveals stability of lipid anchorage as crucial for targeting
(2016)

de la Fuente A, Radchenko V, Tsotakos T, Tsoukalas C, Paravatou-Petsotas M, Harris AL, Koester U, Rösch F, Bouziotis P.
Conjugation, labelling and in vitro/in vivo assessment of an anti-VEGF monoclonal antibody labelled with niobium isotopes.
Chemistry. 2016 Aug 8;22(33):11578-82.
doi: 10.1002/chem.201602758

Radchenko V, Bouziotis P, Tsotakos T, Paravatou-Petsotas M, e la Fuente A, Loudos G, Harris AL, Xanthopoulos S, Filosofov D, Hauser H, Eisenhut M, Ponsard B, Rösch F.
Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept study
Nucl Med Biol. 2016 May;43(5):280-7.
doi: 10.1016/j.nucmedbio.2016.02.003. Epub 2016 Feb 14

Seemann J, Waldron BP, Parker D, Rösch F.
DOTATOC: a novel conjugate for 68Ga labelling of TOC at ambient temperature,
EJNMMI Radiopharmcy 1:4 2016
DOI 10.1186/s41181-016-0007-3

Eppard E, Perez-Malo M, Rösch F.
Improved radiolabeling of DOTATOC with trivalent radiometals for clinical application by addition of ethanol
EJNMMI Radiopharmacy and Chemistry 2016 1:6
DOI: 10.1186/s41181-016-0010-8

Bergmann R, Meckel M, Kubicek V, Steinbach J, Hermann P, Rösch F.
177Lu-labelled macrocyclic bisphosphonates for targeting bone metastasis in cancer treatment
EJNMMIResearch (2016) 6:5
2015
Cremer JN1, Amunts K2, Schleicher A3, Palomero-Gallagher N3, Piel M4, Rösch F4, Zilles K5.
Changes in the expression of neurotransmitter receptors in Parkin and DJ-1 knockout mice - A quantitative multireceptor study.
Neuroscience. 2015 Dec 17;311:539-51
Filosofov D, Lebedev N, Radchenko V, Rakhimov A, Happel S, Rösch F.
Behavior of Actinium, Alkaline, and Rare Earth Elements in Sr-Resin/Mineral Acid Systems
Solvent Extraction and Ion Exchange, 00: 1–14, 2015
Pfannkuchen N, Meckel M, Kubicek V, Hermann P, Bergmann R, Steinbach J, Pietzsch J, Bal CS, Kulkarni HR, Mohnike W, Baum RP, Rösch F.
68Ga- und 177Lu-markierte Bisphosphonate als Knochenmetastasen-Theranostika /// 68Ga- and 177Lu-labeled Bisphosphonates as Theranostic Agents for Bone Metastases
Der Nuklearmediziner, Nuk/565/15.4.2015/MPS, in press
Jurí C, Chana P, Kramer V, Pruzzo P, Amaral H, Riss P, Rösch F.
Imaging Nigrostriatal Dopaminergic Deficit in Holmes Tremor with 18F-PR04.MZ-PET/CT
Clinical Nuclear Medicine 2015, in press
Seemann J, Waldron BP, Rösch F, Parker D.
Approaching 'Kit-Type' Labelling with 68Ga: The DATA Chelators.
ChemMedChem. 2015 Apr 21.
doi: 10.1002/cmdc.201500092. [Epub ahead of print]
Sandhöfer B, Meckel M, Delgado-López JM, Patrício T, Tampieri A, Rösch F, Iafisco M.
Synthesis and preliminary in vivo evaluation of well-dispersed biomimetic nanocrystalline apatites labeled with positron emission tomographic imaging agents.
ACS Appl Mater Interfaces. 7/19 (2015) 10623-33.
doi: 10.1021/acsami.5b02624. Epub 2015 May 7.
Meckel M, Nauth A, Timpe J, Zhernosekov K, Puranik AD, Baum RP, Rösch F.
Development of a [(177)Lu]BPAMD Labeling Kit and an Automated Synthesis Module for Routine Bone Targeted Endoradiotherapy.
Cancer Biother Radiopharm. 2015 Mar;30(2):94-9. doi: 10.1089
Reibel AT1, Müller SS, Pektor S, Bausbacher N, Miederer M, Frey H, Rösch F.
Fate of linear and branched polyether-lipids in vivo in comparison to their liposomal formulations by (18)f-radiolabeling and positron emission tomography.
Biomacromolecules. 2015 Mar 9;16(3):842-51. doi: 10.1021
Poeppel TD, Boy C, Bockisch A, Kotzerke J, Buchmann I, Ezziddin S, Scheidhauer K, Krause BJ, Schmidt D, Amthauer H, Rösch F, Nagarajah J, Führer D, Lahner H, Pöpperl G, Hörsch D, Walter MA, Baum RP.
Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours. German Guideline (S1).
Nuklearmedizin. 2015 Feb 16;54(1):1-11.
Cremer JN, Amunts K, Graw J, Piel M, Rösch F, Zilles K.
Neurotransmitter receptor density changes in Pitx3ak mice--a model relevant to Parkinson's disease.
Neuroscience. 2015 Jan 29;285:11-23. doi: 10.1016
Schieferstein H, Piel M, Beyerlein F, Lüddens H, Bausbacher N, Buchholz HG, Ross TL, Rösch F.
Selective binding to monoamine oxidase A: in vitro and in vivo evaluation of (18)F-labeled β-carboline derivatives.
Bioorg Med Chem. 2015 Feb 1;23(3):612-23. doi: 10.1016
Seemann J, Eppard E, Waldron BP, Ross TL, Rösch F.
Cation exchange-based post-processing of (68)Ga-eluate: A comparison of three solvent systems for labelling of DOTATOC, NO2AP(BP) and DATA(m.).
Appl Radiat Isot. 2015 Apr;98:54-9. doi: 10.1016
Habermeier A1, Graf J, Sandhöfer BF, Boissel JP, Rösch F, Closs EI.
System L amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-L-tyrosine (FET).
Amino Acids February 2015, Volume 47, Issue 2, pp 335-344
 
2014
Radchenko V, Busse S, Rösch F.
Desferrioxamine as an appropriate chelator for 90Nb: comparison of its complexation properties for M-Df-Octreotide (M = Nb, Fe, Ga, Zr).
Nucl Med Biol. 2014 Oct;41(9):721-7. doi: 10.1016/j.nucmedbio.2014.06.006. Epub 2014 Jul 4.
Piel M, Vernaleken I, Rösch F.
Positron Emission Tomography in CNS Drug Discovery and Drug Monitoring
J. Med. Chem. 2014, 57, 9232−9258
dx.doi.org / 10.1021 / jm5001858
Thews O1, Zimny M, Eppard E, Piel M, Bausbacher N, Nagel V, Rösch F.
In vitro and in vivo structure-property relationship of 68Ga-labeled Schiff base derivatives for functional myocardial pet imaging.
Mol Imaging Biol. 2014 Dec;16(6):802-12. doi: 10.1007/s11307-014-0750-3
Eppard E, Loktionova NS, Rösch F.
68Ge content quality control of 68Ge/68Ga-generator eluates and 68Ga radiopharmaceuticals – A protocol for determining the 68Ge content using thin-layer chromatography
Apl Radiat Isot 2014
Piel M, Schmitt U, Bausbacher N, Buchholz HG, Gründer G, Hiemke C, Rösch F.
Evaluation of P-glycoprotein (abcb1a/b) modulation of [18F]fallypride in MicroPET imaging studies
Neuropharmacology Volume 84, September 2014, Pages 152–158
Eppard E, Wuttke M, Nicodemus PL, Rösch F.
Ethanol-Based Post-processing of Generator-Derived 68Ga Toward Kit-Type Preparation of 68Ga-Radiopharmaceuticals.
J Nucl Med. 2014 Apr 21. [Epub ahead of print]
Holub J1, Meckel M, Kubíček V, Rösch F, Hermann P.
Gallium(III) complexes of NOTA-bis (phosphonate) conjugates as PET radiotracers for bone imaging.
Contrast Media Mol Imaging. 2014 May 6.
doi: 10.1002/cmmi.1606. [Epub ahead of print]
V. Radchenko, D. V. Filosofov, O. K. Bochko, N. A. Lebedev, A. V. Rakhimov, H. Hauser,
M. Eisenhut, N. V. Aksenov, G. A. Bozhikov, B. Ponsard, and F. Rösch.
Separation of 90Nb from zirconium target for application in immuno-PET
Radiochim. Acta 2014; 102(5): 433–442
 
2013
Eppard E, Loktionova NS, Rösch F
Quantitative online isolation of 68Ge from 68Ge/68Ga generator eluates for purification and immediate quality control of breakthrough
Applied Radiation and Isotopes 82 (2013) 45-48
Beyerlein F, Piel M, Höhnemann S, Rösch F
Automated synthesis and purification of [18F]fluoro-[di-deutero]methyl tosylate
J. Label Compd. Radiopharm 2013, 56 360-363
Meckel M, Fellner M, Thieme N, Bergmann R, Kubicek V, Rösch F
In vivo comparison of DOTA based 68Ga-labelled bisphononates for bone imaging in non-tumour models
Nuclear Medicine and Biology (40 (2013) 823-830
Martins AF, Prata MIM, Rodrigues SPJ, Geraldes CFGC, Riss PJ, Amor-Coarasa A, Burchardt C, Kroll C, Rösch F
Spectroscopic, radiochemical, and theoretical studies of the Ga3+-N-2hydroxyethyl piperazine-N’-2-ethanesulfonic acid (HEPES buffer) system: evidence for the formation of Ga3+- HEPES complexes in 68Ga labelling reactions
Eur J Nucl Med Mol Imaging 2013, 8 265-273
Vernaleken I, Klomp M, Moeller O, Raptis M, Nagels A, Rösch F, Schaefer WM, Cumming P, Gründer G.
Vulnerability to psychiotic effects of ketamine is associated with elevated D2/3 receptor availability
Int J Neuropsychopharm 16 (2013), 16, 745-754
DOI: 10.1017/S14611457120000764
Allmeroth M, Moderegger D, Gündel D, Buchholz H-G, Mohr N, Koynov A, Rösch F, Thews O, Zentel R
PEGylation of HPMA-based block copolymers enhances tumor accumulation in vivo: A quantitative study using radiolabeling and positron emission tomography.
Journal of Controlled Release 172 (2013) 77–85
Allmeroth M, Moderegger D, Gündel D, Koyonov K, Buchholz H-G, Mohr K, Rösch F, Zentel R, Thews O.
HPMA-LMA copolymer drug carriers in oncology: An in vivo PET study to assess the tumor line-specific polymer uptake and body distribution.
Biomacromolecules 14 (2013) 3091-3101.
dx.doi.org/10.1021/bm400709z
Eppard E, Loktionova NS, Roesch F.
Quantitative online isolation of 68Ge from 68Ge/68Ga generator eluates for purification and immediate quality control of breakthrough.
Appl Rad Isot 82 (2013) 45-48
Zoller F, Riss PJ, Montforts F-P, Kelleher DK, Eppard E, Rösch F
Radiolabelling and preliminary evaluation of 68Ga-tetrapyrrole derivatives as potential tracers for PET
Nuclear Medicine and Biology 40 (2013) 280–288
Eigner S, Beckford Vera DR, Fellner M, Loktionova NS, Piel M, Lebeda O, Rösch F, Roß TL, Eigner Henke K.
Imaging of protein synthesis: In vitro and in vivo evaluation of 44Sc-DOTA-Puromycin
Mol Imaging Biol 15/1 (2013) 79-86
DOI: 10.1007/s11307-012-0561-3
Rösch F
Past, present and future of 68Ge/68Ga generators.
Appl Radiat Isot. 76 (2013) 24-30
doi:pii: S0969-8043(12)00535-0. 10.1016/j.apradiso.2012.10.012.
Rösch F
68Ge/68Ga generators and 68Ga radiopharmaceutical chemistry on their way into a new century.
J Postgrad Med, Edu Res 47(19 (2013) 18-25
Mohnike W, Zimontkowski B, Höhnemann S, Rösch F.
Produktion von PET-Radiopharmaka für den klinischen Gebrauch am Beispiel des MVZ-DTZ Berlin
Der Nuklearmediziner 36 (2013) 27–32
Riss JP, Hoehnemann S, Piel M, Rösch F.
Two-step radiosynthesis of [18F]FE-β-CIT and [18F]PR04.MZ
J. Label Compds. Radiopharm 2013, 56 356-359
Riss PJ, Stockhofe K, Rösch F.
Tropane derived 11C and 18F-labelled DAT ligands
J Lab. Compds. Radiopharm. 56 (2013) 149-158.
DOI: 10.1002/jclr.3018
Vernaleken I, Klomp M, Moeller O, Raptis M, Nagels A, Rösch F, Schaefer WM, Cumming P, Gründer G.
Vulnerability to psychiotic effects of ketamine is associated with elevated D2/3 receptor availability
Int J Neuropsychopharm 16 (2012) 1-10.
DOI: 10.1017/S14611457120000764
Thews O, Dillenburg W, Rösch F, Fellner M.
PET imaging of the impact of extracellular pH and MAP kinases on the p-Glycoprotein (Pgp) activity.
Adv Exp Med Biol. 765 (2013) 279-86.
Cumming P, Xiong G. LaFougere C, Rominger A, Bartenstein P, Buchholz H-G, Piel M, Rösch F, Gründer G, Vernaleken I.
Surrogate markers for cerebral blood flow correlate with [18F]-fallypride binding potential at dopamine D2/3 receptors in human striatum.
Synapse 67/4 (2013) 199-203
10.1002/syn.21630.
Waldron BP, Parker D, Burchardt C, Yufit DS, Zimny M, Rösch F.
Structure and stability of hexadentate complexes of ligands based on AAZTA for efficient PET labelling with gallium-68.
Chem Commun (Camb). 2013 Jan 21;49(6):579-81.
doi: 10.1039/c2cc37544c. Epub 2012 Dec 4.
 
2012
Koumarianou E, Loktionova NS, Fellner M, Rösch F, Thews O, Pawlak D, Archimandritis SC, Mikolajczak R.
44Sc-DOTA-BN[2-14]NH(2) in comparison to 68Ga-DOTA-BN[2-14]NH2 in pre-clinical investigation. Is 44Sc a potential radionuclide for PET?
Appl Radiat Isot. 70/12 (2012) 2669-76.
doi: 10.1016/j.apradiso.2012.08.004. Epub 2012 Aug 23.
Piel M, Rösch F.
Radiopharmaceutical chemistry.
In: G Gründer (ed.) Molecular imaging in the clinical neurosciences. Humana Press / Springer, Springer, New York, Heidelberg, Dordrecht, London, 2012, Pp. 41-73.
DOI: 10.1007/7657 2012 41.
Herth MH, Kramer V, Gillings N, Rösch F, Knudsen GM.
Direct radiofluorination of [18F]MH.MZ for 5-HT2A receptor molecular imaging with PET.
J Label Compd Radiopharm 55 (2012) 354-558.
Best M, Gifford AN, Kim SW, Babst B, Piel M, Rösch F, Fowler JS. 
Rapid radiosynthesis of [11C] and [14C]azelaic, suberic and sebacic acids for in vivo mechanistic studies of systemic acquired resistance in plants.
J. Label. Compd. Radiopharm. 55 (2012) 39-43
Riss PJ, Hooker JM, Shea C, Xu Y, Carter P, Warner D, Ferrari V, Kim SW, Aigbirhio FI, Fowler JS, Rösch F. 
Characterisation of [¹¹C]PR04.MZ in Papio anubis baboon: a selective high-affinity radioligand for quantitative imaging of the dopamine transporter.
Bioorg Med Chem Lett. 22(1) 2012) 679-82.
Rösch F,
Past, present and future of 68Ge/68Ga generators
Appl Radiat Isot 2012
Eigner S, Beckford Vera DR, Fellner M, Loktionova NS, Piel M, Miederer M, Rösch F, Ross T, Eigner Henke K.
Imaging of protein synthesis: in vitro and in vivo evaluation of 44Sc-DOTA-Puromycin.
Mol Imag Biol 2012
Zhernosekov KP, Filosofov DV, Rösch F.
The Szilard-Chalmers effect utilising macrocyclic ligands to increase the specific activity of reactor-produced radiolanthanides: Experiments and explanations.
Radiochim Acta 2012
Riss JP, Hoehnemann S, Piel M, Rösch F.
Two-step radiosynthesis of [18F]FE-β-CIT and [18F]PR04.MZ
2012
Fellner M, Bisalski B, Bausbacher N, Kubícek V, Hermann P, Rösch F, Thews O.
68Ga-BPAMD: PET-imaging of bone metastases with a generator based positron emitter
Nucl Med Biol, 2012
Pruszyński M, Majkowska-Pili A, Loktionova NS, Eppard E, Rösch F.
Radiolabelling of DOTATOC with the long-lived positron emitter 44Sc.
Appl Radiat Isot 70/6 (2012) 974-9.2012.03.005
Rösch F, 
Scandium-44 –Benefits of a long-lived PET radioisotope available from the 44Ti/44Sc generator system.
Current Radiopharmaceutical 5 (2012) 187-201
Rösch F.
Maturation of a key resource – The Germanium-68/Gallium-68 generator: Development and new insights.
Current Radiopharmaceutical 5 (2012) 202-211
Cumming P, Xiong  G. LaFougere C, Rominger A, Bartenstein P, Buchholz H-G, Piel M,  Rösch F, Gründer G, Vernaleken I. 
Surrogate markers for cerebral blood flow correlate with [18F]-fallypride binding potential at dopamine D2/3 receptors in human striatum.
Synapse.
Martins A, Maria P, Geraldes C, Riss P, Coarasa A, Burchardt C, Kroll C, Rösch F,
Spectroscopic, radiochemical, and theoretical studies of the Ga3+-N-2-hydroxyethyl piperazine-N’-2-ethanesulfonic acid (HEPES buffer) system:
Evidence for the formation of Ga3+- HEPES complexes in 68Ga labeling reactions
Contrast Media and Molecular Imaging, 2012
Riss PJ, Burchardt C, Rösch F.
A methodical 68Ga-labelling study of DO2A-(butyl-L-tyrosine)2 with cation-exchanger post-processed 68Ga: practical aspects of radiolabelling.
Contrast Media Mol Imaging. 6(6) (2011) 492-8.
Riss PJ, Burchhardt C, Zimny MJ, Peters J, Rösch F.
A concise synthesis procedure to furnish multi-gram amounts of hexadentate, bivalent DO2A-based chelators    
Organic & Biomolecular Chemistry Manuscript ID OB-ART-01-2012-025082
Radchenko V, Hauser H, Eisenhut M, Vugts DJ, van Dongen GAMS, Rösch F.
90Nb – a potential PET nuclide: production and labeling of monoclonal antibodies
Radiochim Acta 100 (2012) 1–7
Rösch F.
Ge-68/Ga-68 Generators: Past, Present, and Future
RP Baum, F Roesch (eds) Theranostics, Gallium-68 and Other Radionuclides,
Recent Results in Cancer Research 194, Springer, Berlin-Heidelberg, 2012.
Rösch F.
Post-Processing Via Cation Exchange Cartridges: Versatile Options.
RP Baum, F Roesch (eds) Theranostics, Gallium-68 and Other Radionuclides,
Recent Results in Cancer Research 194, Springer, Berlin-Heidelberg, 2012.
Riss PJ, Stockhofe K, Rösch F.
Tropane derived 11C and 18F-labelled DAT ligands
J Lab. Compds. Radiopharm. 2012
 
 
2011
Rösch F, Piel M.
Radiochemie / tracer.
In:Mohnike W, Hör G, Schelbert H (eds.), PET/CT-Atlas: Interdisziplinäre onkologische, neurologische und kardiologische PET/CT-Diagnostik,
2. Auflage, Springer-Verlag, Berlin-Heidelberg, 2011, 35-72.
Riss PJ, Burchardt C, Rösch F.
A methodical 68Ga-labelling study of DO2A-(butyl-L-tyrosine)2 with cation-exchanger post-processed 68Ga: practical aspects of radiolabelling.
Contrast Media Mol Imaging. 6/6 (2011) 492-8.
doi: 10.1002/cmmi.451.
Vértes A, Nagy S, Klencsár Z, Lovas RG, Rösch F (eds.)
Handbook of Nuclear Chemistry, 6 volumes,
Second edition, Springer, Berlin-Heidelberg, 2011
Rösch F (ed.).
Radiochemistry and Radiopharmaceutical Chemistry in Life Sciences.
Vol. 4 of: Handbook of Nuclear Chemistry, Vértes A, Nagy S, Klencsár Z, Lovas RG, Rösch F (eds.)
Second edition, Springer, Berlin-Heidelberg, 2011
Rösch F, Knapp FF.
Radionuclide Generators. Handbook of Nuclear Chemistry, Vértes A, Nagy S, Klencsár Z, Lovas RG, Rösch F (eds.)
Vol. 4, pp 1935-1976, Second edition, Springer, Berlin-Heidelberg, 2011
Novgorodov, AF, Rösch F, Korolev, NA.
Radiochemical separations by thermochromatography.
Handbook of Nuclear Chemistry, Vértes A, Nagy S, Klencsár Z, Lovas RG, Rösch F (eds.) Vol. 5, pp 2429-2458,
Second edition, Springer, Berlin-Heidelberg, 2011
Allmeroth M, Moderegger D, Biesalski B, Koynov K, Rösch F, Thews O, Zentel R.
Modifying the body distribution of HPMA-based copolymers by molecular weight and aggregate formation.
Biomacromolecules. 12(7) (2011) 2841-9.
Hemmelmann M, Knoth C, Schmitt U, Allmeroth M, Moderegger D, Barz M, Koynov K, Hiemke C, Rösch F, Zentel R.
HPMA based amphiphilic copolymers mediate central nervous effects of domperidone.
Macromol Rapid Commun. 32/9-10 (2011) 712-717
Loktionova NS, Belozub AN, Filosofov DV, Zhernosekov KP, Wagner T, Türler A, Rösch F.
Improved column-based radiochemical processing of the generator produced 68Ga.
Applied Radiation Isotopes  69 (2011) 942-6
Rösch F, Baum RP.
Generator-based PET radiopharmaceuticals for molecular imaging of tumours: On the way to THERANOSTICS.
Dalton Transactions 40/23 (2011) 6104-6111
Spreckelmeyer KN, Paulzen M, Raptis M, Baltus T, Schaffrath S, Van Waesberghe J, Zalewski MM, Rösch F, Vernaleken I, Schäfer WM, Gründer G.
Opiate-induced dopamine release is modulated by severity of alcohol dependence: An [18F]fallypride PET study.
Biol Psychiatry 70 (2011) 770-776
Vernaleken I, Peters L, Raptis M, Lin R, Buchholz H-G, Zhou Yun, Winz O, Rösch F, Bartenstein P, Wong D, Schaefer W, Gründer G.
The applicability of SRTM in [18F]Fallypride PET investigations: Impact of scan durations.
JCBFM 31 (2011) 1958–1966
Schmitt U, Lee DE, Herth MM, Piel M, Buchholz H-G, Rösch F, Hiemke C, Lueddens H, Debus F.
P-Glycoprotein influence on the brain uptake of a 5-HT 2A ligand: [18F]MH.MZ.
Neuropsychobiology 63 (2011) 183–190.
Bauman A, Piel M, Höhnemann S, Krauss A, Jansen M, Solbach C, Dannhardt G, Rösch F.
Synthesis, labelling and evaluation of hydantoin-substituted indole carboxylic acids as potential ligands for PET-Imaging of the glycine binding site of the NMDA-receptor.
J Labell Compds Radiopharm 54 (2011) 645-656
Kumar V, Boddeti DK, Evans SC, Rösch F, Howman-Giles R.
Potential use of 68Ga-apo-transferrin as a PET imaging agent for detecting Staphylococcus aureus infection.
Nuclear Medicine and Biology 38 (2011) 393–398
Fellner M, Riss P, Loktionova NS, Zhernosekov KP, Thews O, Geraldes CFGC, Kovacs Z, Lukes I, Rösch F.
Comparison of different phosphorus-containing ligands complexing 68Ga for PET-imaging of bone metabolism.
Radiochimica Acta 99/1 (2011) 43-51.
Fellner M, Dillenburg W, Buchholz HG, Bausbacher N, Schreckenberger M, Renz F, Rösch F, Thews O.
Assessing p-glycoprotein (Pgp) activity in vivo utilizing 68Ga-Schiff base complexes.
Mol Imag Biol.13(5) (2011) 985-94.
 
 
2010
Rösch F, Filosofov DV.
Production, radiochemical processing and quality evaluation of Ge-68, In: IAEA-TEC-DOC Radioisotopes and radiopharmaceuticals, Series 2: Production of Long Lived Parent Radionuclides for Generators: 68Ge, 82Sr, 90Sr and 188W,
International Atomic Energy Agency, Vienna, 2010. ISSN 2077–6462; no. 2, STI/PUB/1436, ISBN 978–92–0–101110–7.
Herth MM, Barz M, Jahn M, Zentel R, Rösch F.
72/74 As-labeling of HPMA based polymers for long-term in vivo PET imaging.
Bioorg Med Chem Lett. 20/18 (2010) 5454-8.
Riss PJ, Piel M, Bockhart V, Bausbacher N, Buchholz HG, Lueddens H, Rösch F.
The DAT ligand [18F]PR17.MZ mirrors the in vivo pharmacokinetic profile of [11C]cocaine with significantly improved monoamine transporter selectivity.
ChemMedChem. 5/10 (2010) 1686-8.
Riss P, Hanik N, Rösch F.
Studies towards the development of lipophilic bifunctional N3S3 chelators for 68Ga.
Radiochim Acta 98/8 (2010) 519-523.
Zoller F, Riss PJ, Montforts F-P, Rösch F.
Efficient post-processing of aqueous generator eluates facilitates 68Ga-labelling under anhydrous conditions.
Radiochim Acta 98/3 (2010) 157-160.
Kramer V, Herth MM, Santini MA, Palner M, Knudsen GM, Rösch F.
Structural combination of established 5-HT receptor ligands: New aspects of the binding mode.
Chem Biol Drug Des. 76(4) (2010) 361-6.
Rösch F, Riss PJ.
The renaissance of the 68Ge/68Ga radionuclide generator initiates new developments in 68Ga radiopharmaceutical chemistry.
Curr Top Med Chem. 10/16 (2010) 1633-68.
Hühn E, Buchholz HG, Shazly G, Maus S, Thews O, Bausbacher N, Rösch F, Schreckenberger M, Langguth P.
Predicting the in vivo release from a liposomal formulation by IVIVC and non-invasive positron emission tomography imaging.
Eur J Pharm Sci. 41/1 (2010) 71-77.
Pruszyński M, Loktionova NS, Filosofov DV, Rösch F.
Post-elution processing of 44Ti/44Sc generator-derived 44Sc for clinical application.
Appl Radiat Isot. 68/9 (2010) 1636-1641
Thews O, Dillenburg W, Fellner M, Buchholz HG, Bausbacher N, Schreckenberger M, Rösch F.
Activation of P-glycoprotein (Pgp)-mediated drug efflux by extracellular acidosis: in vivo imaging with 68Ga-labelled PET tracer.
Eur J Nucl Med Mol Imaging. 37(10) (2010) 1935-42.
Notni J, Hermann P, Havlíčková J, Kotek J, Kubíček V, Plutnar J, Loktionova N, Riss PJ, Rösch F, Lukeš I.
A triazacyclononane-based bifunctional phosphinate ligand for the preparation of multimeric 68Ga tracers for Positron Emission Tomography.
Chemistry. 16/24 (2010) 7174-85.
Vernaleken I, Janouschek H, Raptis M, Hellmann S, Veselinovic T, Bröcheler A, Boy C,
Cumming P, Hiemke C, Rösch F, Schäfer WM, Gründer G.

Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas.
Int J Neuropsychopharmacol. 13/7 (2010) 951-960.
Filosofov DV, Loktionova NS, Rösch F.
A 44Ti/44Sc radionuclide generator for potential application of 44Sc-based PET-radiopharmaceuticals.
Radiochimica Acta 98/3 (2010) 149-156
Debus F, Herth MM, Piel M, Buchholz HG, Bausbacher N, Kramer V, Lüddens H, Rösch F.
18F-labeling and evaluation of novel MDL 100907 derivatives as potential 5-HT2A antagonists for molecular imaging.
Nucl Med Biol. 37(4) (2010) 487-95
Nikisch G, Baumann P, Kießling B, Reinert M, Wiedemann G, Kehr J, Mathé AA, Piel M, Rösch F, Weisser H, Schneider P, Hertel A.
Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first -episode schizophrenia treated with quetiapine.
J Psychiatr Res 44/12 (2010) 754-9.
Rösch F.
Impurity in 68Ga-peptide preparation using processed generator eluate.
J Nucl Med 51 (2010) 496.
Jahn M, Radchenko V, Filosofov D, Hauser H, Eisenhut M, Jennewein M, Rösch F.
Separation and purification of no carrier added arsenic from bulk amounts of germanium being adequate to radiopharmaceutical labeling chemistry.
Radiochim Acta 98/12 (2010) 807-812.
Fellner M, Baum RP, Peters JA, Lukeš I, Hermann P, Prasad V, Rösch F.
PET/CT imaging of osteoblastic bone metastases with 68Ga-bisphosponates - first in human study.
Eur J Nucl Med Mol Imaging 37(4) (2010) 834.
 
 
2009
Riss PJ, Rösch F.
Effective microwave-assisted direct radiosynthesis of [18F]PR04.MZ, and [18F]LBT999: Selective dopamine transporter ligands for quantitative molecular imaging by means of PET.
Bioorg Med Chem 17(22) (2009) 7630-4.
Herth MM, Kramer V, Rösch F.
Synthesis of novel WAY 100635 derivatives containing a norborene group and radiofluoroination of [18F]AH1.MZ, as a Serotonin 5-HT1A receptor antagonist for molecular imaging.
J Label Compd Radiopharm 52/6 (2009) 201-207
Riss PJ, Soskic V, Schrattenholz A, Rösch F.
Synthesis and radiosynthesis of N5-[18F]fluoroethyl-pirenzepine and its metabolite N5-[18F]fluoroethyl-LS 75.
J Label Compd Radiopharm 52 (2009) 576-9.
Riss PJ, Hooker JM, Alexoff D, Kim SW, Fowler JS, Rösch F.
[11C]PR04.MZ, a promising DAT ligand for low concentration imaging: Synthesis, efficient 11C-O-methylation and initial small animal PET studies.
Bioorg Med Chem Lett 19(15) (2009) 4343-5.
Burchardt C, Riss PJ, Zoller F, Maschauer S, Prante O, Kuwert T, Rösch F.
[68Ga]Ga-DO(2)A-(OBu-l-tyr)(2): Synthesis, 68Ga-radiolabeling and in vitro studies of a novel 68Ga-DO(2)A-tyrosine conjugate as potential tumor tracer for PET.
Bioorg Med Chem Lett 19(13) (2009) 3498-501.
Herth MM, Barz M, Moderegger D, Allmeroth M, Jahn M, Thews O, Zentel R, Rösch F.
Radioactive labeling of defined HPMA-based polymeric structures using [18F]FETos for in vivo imaging by Positron Emission Tomography.
Biomacromolecules 10 (2009) 1697-1703
Herth MM, Piel M, Debus F, Schmitt U, Lüddens H, Rösch F.
Preliminary in vivo and ex vivo evaluation of the 5-HT2A imaging probe [18F]MH.MZ.
Nucl Med Biol 36(4) (2009) 447-54.
Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F.
Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.
Bioorg Med Chem. 17(8) (2009) 2989-3002.
Ganguly BN, Mondal NN, Nandy M, Rösch F.
Some physical aspects of positron annihilation tomography:
A critical review
J Radioanal Nucl Chem 279/2 (2009) 685–698
 
 
2008
Vernaleken I, Fellows C, Janouschek H, Bröcheler A, Veselinovic T, Landvogt C, Boy C, Buchholz HG, Spreckelmeyer K, Bartenstein P,
Cumming P, Hiemke C, Rösch F, Schäfer W, Wong DF, Gründer G.
Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).
J Clin Psychopharmacol 28(6) (2008) 608-617.
Riss PJ, Rösch F.
A convenient chemo-enzymatic of trans-1-toluenesulfonyloxymethyl-2-fluoromethyl-cyclopropane.
Org Biomol Chem. 6 (2008) 4567–4574.
Riss PJ, Kroll C, Nagel V, Rösch F.
NODAPA-OH and NODAPA-(NCS)n: Synthesis, 68Ga-radiolabelling and in vitro characterisation of novel versatile bifunctional chelators for molecular imaging.
Bioorg  Med Chem Let. 18 (2008) 5364–5367.
Asti M, De Pietria G, Fraternalia A, Grassib E, Sghedonib R, Fioronib F, Roesch F, Versaria A, Salvoa D.
Validation of 68Ge/68Ga generator processing by chemical purification for routine clinical application of 68Ga-DOTATOC.
Nucl Med Biol 35 (2008) 721-724.
Jennewein M, Lewis MA, Zhao D, Tsyganov E, Slavine N, He J, Watkins L, Antich PP, Hermanne A, Rösch F, Mason RP, Thorpe PE.
Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine.
Clin Cancer Res 14/5 (2008) 1377-85.
Rösch F.
Radiochemistry and Radiopharmaceutical Chemistry for Medicine.
In: Encyclopedia of Life Support Systems, Eolss Publishers Co Ltd, Oxford , UK, 2008
Kienast T, Siessmeier T, Wrase J, Braus DF, Smolka MN, Buchholz HG, Rapp M,
Schreckenberger M, Rösch F, Cumming P, Gruender G,
 Mann K, Bartenstein P, Heinz A.
Ratio of dopamine synthesis capacity to D2 receptor availability in ventral striatum correlates with central processing of affective stimuli.
Eur J Nucl Med Mol Imaging 35 (2008) 1147-1158.
Herth MM, Debus F, Piel M, Palner M, Knudsen GM, Lüddens H, Rösch F.
Total synthesis and evaluation of [18F]MH.MZ.
Bioorg Med Chem Lett. 18(4) 2008 1515-1519.
Vernaleken I, Fellows C, Janouschek H, Bröcheler A, Veselinovic T, Landvogt C, Boy C,
Buchholz H-G, Bartenstein P, Cumming P, Hiemke C,
Rösch F, Schäfer W, Wong DF, Gründer G.
Striatal and extrastriatal D2/3 receptor binding properties of Ziprasidone: a PET study with [18F]Fallypride.
J Clin Psychopharmacol 28(6) (2008) 608-17.
Gründer G, Fellows C, Janouschek H, Veselinovic T, Boy C, Bröcheler A, Kirschbaum KM, Hellmann S, Spreckelmeyer KM, Hiemke C, Rösch F, Schaefer WM, Vernaleken I.
Brain and plasma pharmacokinetics of Aripiprazole in patients with Schizophrenia: An [18F]Fallypride PET study.
Am J Psychiatry 165 (2008) 985-988.
Fehr C, Yakushev I, Hohmann N, Buchholz H-G, Landvogt C, Deckers H, Eberhardt A, Kläger M, Smolka MN, Scheurich A, Dielentheis T, Schmidt LG, Rösch F, Bartenstein P, Gründer G, Schreckenberger M.
Association of low striatal dopamine D2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse.
Am J Psychiatry 165 (2008) 507-515.
Betzel T, Heß T, Waser B, Reubi J-C, Rösch F.
closo-Borane conjugated regulatory peptides retain high biological affinity: Synthesis of closo-Borane conjugated Tyr3-Octreotate derivatives for BNCT.
Bioconjug Chem. 19(9) (2008) 1796-802.
 
 
2007
Zhernosekov KP, Filosofov DV, Baum RP, Aschoff P, Bihl H, Razbash AA, Jahn M, Jennewein M, Rösch F.
Processing of generator-produced 68Ga for medical application.
J Nucl Med. 48 (2007) 1741-1748.
Piel M, Bauman A, Baum RP, Höhnemann S, Klette I, Wortmann R, Rösch F.
Improved automated synthesis of [18F]fluoroethylcholine as a radiotracer for cancer imaging.
Bioorg Med Chem 15 (2007) 3171-3175.
Zhernosekov KP, Filosofov DV, Qaim SM, Rösch F.
A 140Nd/140Pr radionuclide generator based on physico-chemical transitions in 140Pr complexes after electron capture decay of 140Nd-DOTA.
Radiochim Acta 95 (2007) 319-327.
Rösch F.
Radiolanthanides in endoradiotherapy: an overview.
Radiochim Acta 95 (2007) 303-311.
Stark D, Piel M, Hübner H, Gmeiner P, Gründer G, Rösch F.
In vitro affinities of various halogenated benzamide derivatives as potential radioligands for non-invasive quantification of D2-like dopamine receptors.
Bioorg Med Chem 15 (2007) 6819-6829.
Vernaleken I, Weibrich C, Siessmeier T, Buchholz H-G, Rösch F, Heinz A, Cumming P, Stoeter P, Bartenstein P, Gründer G.
Asymmetry in dopamine D2/3 receptors of NC is lost with age.
Neuroimmage 34 / 3 (2007) 870-878.
 
 
2006
Siessmeier T, Kienast T, Wrase J, Larsen JL, Braus DF, Smolka MN, Buchholz HG, Schreckenberger M,  Rösch M, Cumming P, Mann K, Bartenstein P, Heinz A.
Antiamphiphysin-positive stiff-person syndrome associated with small cell lung cancer.
Mov Disord. 21 (2006) 1285-1287.
Rösch F, Zhernosekov KP, Filosofov DV, Jahn M, Jennewein M.
The status and the potential of new radionuclide generators providing positron emitters to synthesise new targeting vectors for PET
IAEA-CN-130/068, 2006.
Gründer G, Landvogt C, Vernaleken I, Buchholz HG, Ondracek J, Siessmeier T, Hartter S, Schreckenberger M, Stoeter P, Hiemke C, Rösch F, Wong DF, Bartenstein P.
The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
Neuropsychopharmacology 31(5) (2006) 1027-35.
Siessmeier T, Kienast T, Wrase J, Larsen JL, Braus DF, Smolka MN, Buchholz HG, Schreckenberger M, Rösch F, Cumming P, Mann K, Bartenstein P, Heinz A.
Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli.
Eur J Neurosci 24(1) (2006) 305-13.
Tsyganov EN, Anderson J, Arbique G, Constantinescu A, Jennewein M, Kulkarni PV, Mason RP, McColl RW, Öz OK, Parkey RW, Richer E, Rösch F, Seliounine SY, Slavine NV, Srivastava SC, Thorpe PE, Zinchenko AI, Antich PP.
UTSW small animal positron emission imager.
IEEE Transactions on Nuclear Science, 53 (2006) 2591-2600.
Rösch F, Gründer G, Schreckenberger M, Dannhardt G.
Radiopharmazeutische Entwicklungen für die Molekulare Bildgebung von Prozessen im Zentralen Nervensystem.Healthy Academy 01/2006, pp. 38-53. in: Molecular Imaging. Innovationen und Visionen in der medizinischen Bildgebung.
Herausgeber: W Niederlag, H U Lemke, W Semmler, C Bremer.
Wängler B, Beck C, Wagner-Utermann U, Schirrmacher E, Bauer C, Rösch F, Schirrmacher R, Eisenhut M.
Application of tris-allyl-DOTA in the preparation of DOTA-peptide conjugates.
Tetrahedron Lett 47 (2006) 5985 – 5988.
Odenwald T, Nakagawa K, Hadstein Ch, Rösch F, Gohlke P, Schäfer F, Ritz E, Schmitt CP.
Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic rats.
J Am Soc Nephrology 17(3) (2006) 655-62.
Bartoli A, Belcari N, Stark D, Höhnemann S, Piel M, Jennewein M, Schmitt U, Tillmanns J,
Thews O, Hiemke Ch, Rösch F, Del Guerra A.
 
Preliminary assessment of the imaging capability of the YAP-(S)PET small animal scanner in neuroscience
Nucl Instr Methods A 569 (2006) 488-491.
Werhahn KJ, Landvogt CH, Klimpe S, Buchholz H-G, Müller-Forell W, Yakushev I, Piel M, Rösch F, Schreckenberger M, Bartenstein P.
Decreased temporal dopamine D2/D3 receptor binding in temporal lobe epilepsy: an 18F-Fallypride PET study.
Epilepsia 47 (2006) 1392-1396.
Novgorodov AF, Korolev NA,  Rösch F.
A combined 148Gd / 244Cm source for energy calibration of α-spectrometers
Appl Radiat Isot 64 (2006) 540-542.
Baumgärtner U, Buchholz H-G, Bellosevich A, Magerl W, Siessmeier T, Rolke R, Höhnemann S, Piel M, Rösch F, Wester H-J, Henriksen G, Stoeter P, Bartenstein P,
Treede R-D, Schreckenberger M.
High opiate receptor binding potential in the human lateral pain system.
Neuroimage 30 (2006) 692-699.
Jennewein M, Hermanne A, Mason RP, Thorpe PE, Rösch F.
A new method for the labelling of proteins with radioactive arsenic isotopes
Nucl Instr Methods A 569 (2006) 512-517.
Uusijärvi H, Bernhardt P, Mäcke H, Rösch F, Forssell-Aronsson E.
Electron and positron-emitting radiolanthanides for therapy – A dosimetric and production evaluation
J Nucl Med 47 (2006) 807-814.
 
 
2005
Herzog H, Rösch F.
Chemistry and physics of scanners. PET- and SPECT-techniques.
Pharm Unserer Zeit 34(6) (2005) 468-73.
Rösch F, Gründer G, Schreckenberger M, Dannhardt G.
Radiopharmaceutical strategies and clinical applications. Diagnosis of CNS disease with PET as well as SPECT.
Pharm Unserer Zeit 34(6) (2005) 474-82. Erratum in: Pharm Unserer Zeit 35(1) (2006) 7.
Heinz A, Siessmeier T, Wrase J, Buchholz HG, Gründer G, Kumakura Y, Cumming P, Schreckenberger M, Smolka MN, Rösch F, Mann K, Bartenstein P.
Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: A combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients.
Am J Psychiatry 8 (2005) 1515-20.
Helisch A, Schirrmacher E, Thews O, Schirrmacher R, Buchholz HG, Dillenburg W, Höhnemann S, Tillmanns J, Wessler I, Buhl R, Rösch F, Bartenstein P.
Demonstration of pulmonary beta(2)-adrenergic receptor binding in vivo with [18F]fluoroethyl-fenoterol in a guinea pig model.
Eur J Nucl Med Mol Imaging 32 (2005) 1324-1328.
Jennewein M, Qaim SM, Kulkarni PV, Mason RP,  Hermanne A, Rösch F.
A no-carrier-added 72Se/72As radionuclide generator based on solid phase extraction
Radiochim Acta 93 (2005) 579-583.
Jennewein M, Qaim SM, Hermanne A, Jahn M, Tsyganov E, Slavine N, Seliounine S, Antich PA,  Kulkarni PV, Thorpe PE, Mason RP, Rösch F.
A new method for radiochemical separation of arsenic from irradiated germanium oxide
Appl Radiat Isot 63 (2005) 343–351.
Klein ATJ, Rösch F, Coenen HH, Qaim SM.
Labelling of manganese-based magnetic resonance imaging (MRI) contrast agents with the positron emitter 51Mn, as exemplified by manganese-tetraphenyl-porphin-sulfonate (MnTPPS4)
Appl Rad Isot 62 (2005) 711-720.
Mühlhausen Ü, Schirrmacher R, Piel M, Lecher B, Nagel G, Pie-Staffa A, Kaina B, Rösch F.
Synthesis of I-131 labeled glucose-conjugated inhibitors of O6-Methylguanine-DNA Methyltransferase (MGMT) and comparison with non-conjugated inhibitors as potential tools for in vivo MGMT imaging
J Med Chem, 12 (2005) 263-72.
Schneider S, Feilen PJ, Schreckenberger M, Schwanstecher M, Schwanstecher C, Buchholz HG, Thews O, Oberholzer K, Korobeynikov A, Bauman A, Comagic S, Piel M, Schirrmacher E, Shiue CY, Alavi AA, Bartenstein P, Rösch F, Weber MM, Klein HH, Schirrmacher R.
In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans.
Exp Clin Endocrinol Diabetes 7 (2005) 388-395.
Siessmeier T, Yun Zhou, Buchholz H-G, Landvogt CH, Vernaleken I, Piel M, Schirrmacher R, Rösch F,  Schreckenberger M, Wong D-F, Cumming P, Gründer G, Bartenstein P.
Parametric mapping of the binding in human brain of D2-receptor ligands of different affinities
J Nucl Med 6 (2005) 964-97
Yakushev EA, Kovalík A, Filosofov DV, Korolev NA, Lebedev NA, Lubashevski AV, Rösch F,  Novgorodov AF.
An experimental comparison of the K- and L-Auger electron spectra generated in the decays of 140Nd and 111In.
Appl Radiat Isot 62 (2005) 451-456.
Zhernosekov K, Aschoff P, Filosofov D, Jahn M, Jennewein M, Adrian HJ, Bihl H, Rösch F.
Visualisation of a somatostatin receptor-expressing tumour with 67Ga-DOTATOC SPECT.
Eur J Nucl Med Mol Imaging 32 (2005) 1129.
 
 
2004
Vernaleken I , Siessmeier T, Buchholz H-G, Härtter S, Hiemke Ch, Stoeter P,  Rösch F,
Bartenstein P,  Gründer G.

High striatal occupancy of D2-like dopamine receptors by amisulpride in brain of schizophrenic patients: implications for atypical antipsychotic mechanism of action.
Int J Neuropsychopharmacol 7/4 (2004) 421-430.
Rösch F.
Radionuklid-Generatorsysteme für die PET
Der Nuklearmediziner 27 (2004) 226-235.
Heinz A, Siessmeier T, Wrase J, Hermann D, Klein S, Grüsser-Sinopoli SM, Flor H, Braus DF,
Buchholz H-G, Gründer G, Schreckenberger M, Smolka M, Rösch F,
Mann K, Bartenstein P.
Correlation between dopamine D2 receptors in the ventral striatum and central processing of alcohol cues and craving.
Am J Psychiatry 161 (2004) 1783-1789.
Wängler B, Beck C, Shiue CY, Schneider S, Schwanstecher C, Schwanstecher M, Feilen PJ,
Alavi A,  Rösch F, Schirrmacher R.

Synthesis and in vitro evaluation of (S)-2-([11C]methoxy)-4-[3-methyl-1-(2-piperidine-1-yl-phenyl)-butyl-carbamoyl]-benzoic acid ([11C]methoxy-repaglinide):
a potential beta-cell imaging agent.
Bioorg Med Chem Lett 14/20 (2004) 5205-5209.
Schreckenberger M, Hägele S, Siessmeier T, Buchholz HG, Armbrust-Henrich H, Rösch F,
Gründer G, Bartenstein P, Vogt T.

The dopamine D2-like receptor ligand 18F-Desmethoxyfallypride: An appropriate fluorinated PET tracer for the differential diagnosis of Parkinsonism.
Eur J Nucl Med Mol Imaging 8 (2004) 1128-1135.
Kaina B, Mühlhausen U, Piee-Staffa A, Christamnn M, Garcia Boy R, Rösch F, Schirrmacher R.
Inhibition of O6-methylguanine-DNA methyltransferase (MGMT) by glucose-conjugated inhibitors: Comparison with non-conjugated inhibitors and effect on fotemustine and temolozomide-induced cell death.
J Pharmacol Exptl Therap 311 (2004) 585-593.
Rösch F, Forssell-Aronsson E.
Radio-lanthanides in Nuclear Medicine.
in Metal Ions and Their Complexes in Medication (2004) Vol. 42. p. 77-108, A. Sigel, H. Sigel, Eds. M. Dekker, Inc., New York & Basel.
Mauerhofer E, Zhernosekov K, Rösch F.
Limiting transport properties and hydratation numbers of actinyl ions in pure water.
Radiochim Acta 92 (2004) 5-10.
Jennewein M, Schmidt A, Novgorodov AF, Qaim SM, Rösch F.
A no-carrier-added 72Se/72As radionuclide generator based on distillation.
Radiochim Acta 92 (2004) 245-249.
Schmitz A, Shiue C-Y, Feng Q, Shiue GG, Deng S, Pourdehnad MT, Schirrmacher R,
Vatamaniuk M,  DolibaN, Matschinsky F, Wolf B, Rösch F, Naji A, Alavi AA.

Synthesis and evaluation of fluorine-18 labeled glyburide analogs as beta-cell imaging agents.
Nucl Med Biol 31 (2004) 483-491.
Wängler B, Schneider S, Thews O, Schirrmacher E, Comagic S, Feilen P, Schwanstecher C, Schwanstecher M, Shiue C-Y, Alavi A, Höhnemann S, Piel M, Rösch F, Schirrmacher R. Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission tomography (PET).
Nucl Med Biol 31 (2004) 639-647.
Schirrmacher R, Comagic S, Schirrmacher E, Rösch F.
Synthesis of a technetium-99m labeled L-tyrosine derivative with the fac-99mTc(I)(CO)3-core for imaging cancer.
J Label Compd Radiopharm 47 (2004) 477-483.
 
 
2003
Rösch F, Knapp FF (Russ).
Radionuclide Generators.in A Vértes, S Nagy, Z Klencsár, F Rösch (eds.),
Handbook of Nuclear Chemistry – Vol. 4, pp 81-118, 2003, Kluwer Academic Publishers, The Netherlands
Rösch F (ed).
Radiochemistry and Radiopharmaceutical chemistry in Life Sciences.Volume 4 of the Handbook, in A Vértes, S Nagy, Z Klencsár, (eds.),
Handbook of Nuclear Chemistry, 2003, Kluwer Academic Publishers, The Netherlands
Rösch F, Wester H-J, Qaim S M.
In memoriam Gerhard Stöcklin.in Vértes A, Nagy S,  Klencsár Z (eds.),
Handbook of Nuclear Chemistry – Vol. 4, pp xi-xiv, 2003, Kluwer Academic Publishers, Netherlands
Bauman A, Piel M, Schirrmacher R, Rösch F.
Efficient alkali iodide promoted 18F-fluoroethylations with 2-[18F]fluoroethyl tosylate and 1-bromo-2-[18F]fluoroethane
Tetrahedron Letters 44 (2003) 9165-9167
Novgorodov A F, Rösch F, Korolev N A.
Radiochemical Separations by Thermochromatography.
in A Vértes, S Nagy, Z Klencsár (eds.),
Handbook of Nuclear Chemistry – Vol. 5, pp 227-259, 2003, Kluwer Academic Publishers, The Netherlands
Schirrmacher E, Schirrmacher R, Beck C, Mier W, Trautmann N, Rösch F.
Synthesis of a Tyr3-octreotate conjugated closo-carborane [HC2B10H10]: a potential compound for boron neutron capture therapy.
Tetrahedron Lett 44 (2003) 9143-9145
Piel M, Schirrmacher R, Höhnemann S, Hamkens W, Kohl B, Jansen M, Schmitt U, Lüddens H, Dannhardt G,  Rösch F.
Synthesis and evaluation of 5,7-dichloro-4-(3-{4-[4-(2-[18F]fluoroethyl)-piperazin-1-yl]-phenyl}-ureido)-1,2,3,4-tetrahydroquinoline-2-carboxylic acid as a potential NMDA ligand to study glutamergic neurotransmission in vivo. 
J Label Compd Radiopharm 46 (2003) 645-659
Buchholz HG, Herzog H, Förster GJ, Reber H, Nickel O, Rösch F, Bartenstein P.
PET Imaging with Yttrium-86: Comparison of phantom measurements acquired with different PET scanners before and after applying background subtraction.
Eur J Nucl Med 30 (2003) 716-720
Schirrmacher E, Schirrmacher R, Helisch A, Dillenburg W, Thews O, Wessler I, Buhl R, Höhnemann S,  Buchholz HG, Bartenstein P, Machulla HJ, Rösch F.
Synthesis and preliminary evaluation of (R,R) (S,S) -(2-(2-[4-(2-[F-18]fluoroethoxy)phenyl]-1-methylamino)-1-hydroxyethyl)benzene-1,3-diol ([F-18]FEFE) for the in vivo visualisation and quantification of the ß2-adrenergic receptor status in lung.
Biomed Chem Lett 13/16 (2003) 2687-2692
Gründer G, Siessmeier T, Piel M, Vernaleken I, Buchholz H-G, Yun Zhou, Hiemke Ch, Wong D, Rösch F, Bartenstein P.
Quantification of D2-like dopamine receptors in the human brain with [18F]desmethoxyfallypride.
J Nucl Med 44 (2003) 109-116
Schirrmacher R, Mathiasch B, Schirrmacher E, Radnic D, Rösch F.
Syntheses of novel N-([18F]fluoroalkyl)-N-nitroso-4-methyl-benzensulfonamides and decomposition studies of corresponding 19F- and bromo-analogues: Potential new compounds for the 18F-labelling of radiopharmaceuticals.
J Label Compd Radiopharm 46 (2003) 959-977
Schildan A, Schirrmacher R, Schirrmacher E, Samochocki M, Christner C, Maelicke A, Rösch F.
Synthesis and evaluation of tritium labelled 10-methylgalanthamine iodide: A novel compound to examine the mechanism of interaction of galanthamine derivatives with nicotinic acetylcholine receptors.
J Label Compd Radiopharm 46 (2003) 1117-1125
Zhernosekov KP, Mauerhofer E, Getahun G, Warwick P, Rösch F.
Complex formation of Tb3+ with glycolate, D-gluconate and a-isosaccharinate in neutral aqueous perchlorate electrolytes.
Radiochim Acta 91 (2003) 599-602
Mauerhofer E, Zhernosekov K, Rösch F.
Limiting transport properties of lanthanide and actinide ions in pure water.
Radiochim Acta 91 (2003) 473-477
 
 
2002
Busse S, Rösch F, Qaim SM.
Cross section data for the production of the positron emitting niobium isotope 90Nb via the 90Zr(p,n)-reaction.
Radiochim Acta 90 (2002) 1-5
Schirrmacher R, Nesseler E, Hamkens W, Eichhorn U, Schreckenberger M, Kaina B, Rösch F.
An approach to the evaluation of the activity of the DNA repair enzyme O6-methylguanine-DNA-methyl-transferase in tumor tissue in vivo: synthesis of 6-benzyloxy-9-(2-[18F]fluoroethyl)-9H-purin-yl-2-amine and 6-benzyloxy-7-(2-[18F]fluoroethyl)-9H-purin-yl-2-amine.
Appl Radiat Isot 56 (2002) 511-517
Klein ATJ, Rösch F, Coenen HH, Qaim SM.
Production of the positron emitter 51Mn via the 50Cr(d,n) reaction: targetry and separation of n.c.a. radiomanganese.
Radiochim Acta 90 (2002) 167-177
Busse S, Brockmann J, Rösch F.
Radiochemical separation of no-carrier-added radioniobium from zirconium targets for application of 90Nb labelled compounds.
Radiochim Acta 90 (2002) 411-415
Schirrmacher R, Wängler B, Schirrmacher E, August T, Rösch F.
Dimethylpyridin-4-ylamine-catalysed alcoholysis of 2-amino-N,N,N-trimethyl-9H-ylammonium chloride: An effective route to O6-substituted guanine derivatives from alcohols with poor nucleophilicity.
Synthesis 4 (2002) 538-542
Comagic S, Piel M, Schirrmacher R, Höhnemann S, Rösch F.
Efficient synthesis of 2-bromo-1-[18F]fluoroethane and its application in the automated preparation of 18F-fluoroethylated radiopharmaceuticals.
Appl Radiat Isot 56 (2002) 847-851
Schirrmacher R, Weber M, Schmitz A,  Shiue CY, Alavi AA, Feilen P, Schneider S, Kann P,
Rösch F.

Radiosynthesis of 1-(4-(2-[18F]fluoroethoxy)benzenesulfonyl)-butyl urea: A potential β-cell imaging agent.
J Label Compd Radiopharm 45 (2002) 763-774
Reischl T, Rösch F, Machulla HJ.
Electrochemical separation and purification of yttrium-86.
Radiochim Acta 90 (2002) 225-228
Schirrmacher R, Mühlhausen U, Wängler B, Schirrmacher E, Reinhard J, Nagel G, Kaina B, Piel M,  Wießler M, Rösch F.
Synthesis of 2-amino-6-(2-[18F]fluoro-pyridine-4-ylmethoxy)-9-(octyl-b-D-glycosyl)-purine: A novel radioligand for positron emission tomography studies of the O6-methylguanine-DNA methyltransferase (MGMT) status of tumour tissue.
Tetrahedron Letters 43 (2002) 6301-6304
Filosofof DV, Novgorodov AF, Korolev NA, Egorov VG, Lebedev NA, Akselrod ZZ, Brockmann J, Rösch F.
Development of the Gamma-Gamma perturbed angular correlation one-detector method for the studies of the physicochemical properties of matter.
Appl Radiat Isotopes 57/3 (2002) 437-443
Mauerhofer E, Kling O, Rösch F.
Dependence of the mobility of tracer ions in aqueous perchlorate solutions on the hydrogen ion concentration.
Phys. Chem. Chem. Phys. 5/1/ (2002) 117 – 126
 
 
2001
Schirrmacher R, Shiue G, Shiue SJ, Alavi A, Feilen PJ, Schneider S, Beyer J, Rösch F.
Synthesis and first evaluation of new 18F-labelled sulfonylureas for the determination of the beta-cell status in vivo.
J Label Compd Radiopharm 44 (2001) 418-420
Novgorodov AF, Schmidt A, Brockmann J, Rösch F, Qaim SM.
A no-carrier-added 72Se/72As isotope generator.
J Label Compd Radiopharm 44 (2001) 778-780
Mauerhofer E, Kling O, Rösch F.
Electroosmotic effects in the determination of individual ion mobilities of carrier-free radionuclides in free aqueous electrolyte solutions.
Radiochim Acta 89 (2001) 537-541
Schirrmacher G, Hamkens W, Piel M, Schmitt U, Lüddens H, Hiemke Ch, Rösch F.
Radiosynthesis and evaluation of (2-((4-(2-[18F]fluoroethoxy)phenyl)bis(4-methoxyphenyl)methoxy)-ethylpiperidine-3-carboxylic acid as a potential GAT-3 ligand to study GABAergig neurotransmission in vivo.
J Label Compd Radiopharm 44 (2001) 627-642
Schirrmacher E, Schirrmacher R, Buhl R, Wessler I, Machulla HJ, Rösch F.
Synthesis of [18F]fluoroethylfenoterol for imaging β2 receptor status in lung in vivo.
J Label Compd Radiopharm 44 (2001) 436-438
Wolf B, Schirrmacher R, Förster GJ, Bartenstein P, Rösch F.
Synthesis and first in vivo-tests of C1-[18F]Ffluoroethylamino asparagine for imaging cancer.
J Label Compd Radiopharm 44 (2001) 365-367
Comagic S, Piel M, Schirrmacher R, Höhnemann S, Rösch F.
Efficient synthesis of 2-bromo-1-[18F]fluoroethane and its application in the automated preparation of 18F-fluoroethylated radiopharmaceuticals.
J Label Compd Radiopharm 44 (2001) 874-876
A Schildan, R Schirrmacher, M Samochocki, C Christner, A Maelicke, F Rösch.
Synthesis and in vitro evaluation of galanthamine derivatives for examination of nicotinic acetylcholine receptor system.
J Label Compd Radiopharm 44 (2001) 247-249
G Gründer, T Siessmeier, C Lange-Asschenfeldt, I Vernaleken, H-G Buchholz, P Stoeter, A Drzezga, H Lüddens, F Rösch, P Bartenstein.
[18F]fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors.
Eur J Nucl Med 28 (2001) 1463-1470
 
 
2000
Rösch F, Brockmann J, Lebedev NA, Qaim SM.
Production and radiochemical separation of the Auger electron emitter 140Nd.
Acta Oncologica, 39 (2000) 727-730
Lebedev NA, Novgorodov AF, Misiak R, Brockmann J, Rösch F.
Radiochemical separation of no-carrier-added 177Lu as produced via the 176Yb(n,)177Yb  177Lu process.
Appl Radiat Isot, 53 (2000) 421-425
Novgorodov AF, Bruchertseifer F, Brockmann J, Lebedev NA, Rösch F.
Thermochromatographic separation of no-carrier-added 186Re or 188Re from tungsten targets relevant to nuclear medical applications.
Radiochim Acta 88 (2000) 163-167
Klein ATJ, Rösch F, Qaim SM.
Investigation of 50Cr(d,n) 51Mn and natCr(p,x) 51Mn processes with respect to the production of the positron emitter 51Mn.
Radiochim Acta, 88 (2000) 253-264
Mauerhofer E, Kling O, Hiller K, Rösch F.
A device for on-line electromigration measurements of radioelements in free electrolytes.
Radiochim Acta 88 (2000) 399-400
Schirrmacher R, Hamkens W, Rösch F.
Synthesis of Tritium-labeled (±)-1-[2-(triphenylmethoxy)ethyl]-3-piperidine-carboxylic acid: A possible compound to determine the efficacy of potential GABA transporter substances in vivo.
J Lablled Compd Radiopharm 43 (2000) 1127-1134
Hamkens H, Rösch F.
FDG: Biochemical concept and radiochemical synthesis.
In: Wieler HJ, Coleman RE (eds.), PET in Clinical Oncology, Steinkopff,
Darmstadt, 2000, 55-66
Rösch F, Wester HJ, Degrado Tr.
Current developments of 18F-labeled PET-tracers in oncology.
In: Wieler HJ, Coleman RE(eds.), PET in Clinical Oncology, Steinkopff,
Darmstadt, 2000, 55-66
 
 
1999
Lebedev NA, Novgorodov AF, Brockmann J, Rösch F.
Production of no-carrier-added 177Lu via the 176Yb(n, )177Yb  177Lu process and its radiochemical separation.
Label Compd Radiopharm 42, suppl. 1 (1999) 924-926
Rösch F, Brockmann J, Lebedev NA, Qaim SM.
The Auger-electron emitter 140Nd: Production and radiochemical separation.
J Label Compd Radiopharm 42, suppl. 1 (1999) 927-929
Bruchertseifer F, Brockmann J, Novgorodov AF, Lebedev NA, Rösch F.
Thermochromatographic separation of 186/188Re from tungsten targets used to design a 188W/188Re generator or to separate 186Re as produced via the 186W(p,n) reaction.
J Label Compd Radiopharm 42, suppl 1 (1999) 930-932
Busse S, Brockmann J, Rösch F.
Effecitve radiochemical separation of no-carrier-added 90g/95gNb from macroscopic amounts of natZr.
J Label Compd Radiopharm 42, suppl. 1 (1999) 906-908
Klein ATJ, Rösch F, Qaim SM.
electrolytic preparation of isotopically enriched hard chromium layers on gold backings for nuclear reaction studies.
J Electrochem Soc 146 (1999) 4526-4534
Hamkens W, Piel M, Schirrmacher R, Schmitt U, Kleinz R, Lüddens H, Gründer G, Rösch F.
Improved synthesis of 5-(2’-[18F]fluoroethyl)flumazenil for in vivo imaging of benzodiazepine receptors.
J Label Compd Radiopharm 42, suppl. 1 (1999) 510-512
Brockmann J, Rösch F.
Determination of stability constants in Y-DTPA-peptide-systems: Evaluation of a radiochemical method using n.c.a. yttrium-88.
Radiochim Acta 87 (1999) 79-85
Neumaier B, Rösch F.
Ternary Complex Formation of Lanthanides with Phosphate and Serum Proteins in Blood.
Radiochim Acta 84 (1999) 201-204
Stolz B, Bruns C, Albert R, Rösch F, Smith-Jones P, Raulf F, Hoyer D, Weckbecker G.
Somatostatin receptor-targeted radiotherapy – preclinical proof of concept.
in: Octreotide: The Next Decade, Ed S W J Lamberts, BioScientifica Ltd. (1999) pp 1-
Rösch F, Herzog H, Neumaier B, Müller-Gärtner HW, Stöcklin G.
Quantitative whole-body pharmacokinetics of Yttrium-86 complexes with PET and radiation dose calculation of analogous Yttrium-90 radiotherapeuticals.
Conference proceedings „Sixth International Radiopharmaceutical Dosimetry Symposium“
Gatlinburg, Tennessee (1999) pp 101-110
Rösch F, Herzog H, Stolz B, Brockmann J, Köhle M, Mühlensiepen H, Marbach P, Müller-Gärtner HW.
Uptake kinetics of the somatostatin receptor ligand [86Y]DOTA-Dphe1-Tyr3-octreotide ([86Y]SMT 487) using positron emission tomography in non-human primates and calculation of radiation doses of the 90Y-labelled analogue.
Eur J Nucl Med 26 (1999) 358-366
Brockmann J, Schmidt A, Rösch F.
Radiolabelling of model compounds with [76As]As-arsonic acid and investigation of their stability.
J Label Compd Radiopharm 42, suppl. 1 (1999) 759-761
Brockmann J, Schmidt A, Rösch F.
Synthesis of carrier-added arsonic acids as precursors for the radiolabelling with arsenic radioisotopes.
J Label Compd Radiopharm 42, suppl. 1 (1999) 303-305
Busse S, Brockmann J, Rösch F.
[90gNb]DFO-succinyl-(D)Phe1-octreotide: First radiolabeling experiments of DFO-succinyl-(D)Phe1-octreotide (SDZ 216-927) with analogeous no carrier added 95gNb and investigation of its in vitro stability. J Label Compd Radiopharm 42, suppl. 1 (1999) 300-302
Nesseler E, Schirrmacher R, Hamkens W, Rösch F.
Synthesis of 2-amino-6-benzyloxy-9-[18F]fluoroethyl-purine, a possible candidate to determine the status of O6-methyl-guanine-DNA-methyltransferase (MGMT) of tumor tissue.
J Label Compd Radiopharm 42, suppl. 1 (1999) 198-200
Schirrmacher R, Hamkens W, Piel M, Brockmann J, Rösch F.
Synthesis of 18F- and 11C-labeled substituted triarylnipecotic acid derivatives with high affinity for the GABA transporter GAT-3.
J Label Compd Radiopharm 42, suppl. 1 (1999) 339-341
Piel M, Schirrmacher R, Hamkens W, Schmitt U, Hiemke C, Gründer G, Rösch F.
Improved precursor synthesis and 18F-fluorination of [18F]desmethoxyfallypride.
J Label Compd Radiopharm 42, suppl. 1 (1999) 381-383
Hamkens H, Rösch F.
FDG: Biochemisches Konzept und radiochemische Synthese.
In: HJ Wieler (ed.), PET in der klinischen Onkologie, Steinkopff Verlag,
Darmstadt, 1999, 59-70
Rösch F.
Aktuelle Entwicklungen 18F-markierter onkologischer PET-Tracer.
In: HJ Wieler (ed.), PET in der klinischen Onkologie, Steinkopff Verlag,
Darmstadt, 1999, 71-84
Griffiths GL, Goldenberg DM, Roesch F, Hansen HJ.
Radiolabelling of an anti-carcinoembryonic antigen antibody Fab´ fragment (CEA-Scan) with the positron-emitting radionuclide Tc-94m,
Clin Cancer Res 5 (1999) 3001-3003
 
 
1998
Neumaier B, Rösch F.
Ternary complex formation between yttrium, phosphate and serum proteins:
Physicochemical state of yttrium in blood. Radiochim Acta 81 (1998) 171-177
 
 
1997
Denzler FO, Lebedev NA, Novgorodov AF, Rösch F, Qaim SM.
Production and radiochemical separation of 147Gd.
J Appl Radiat Isot 48 (1997) 319-326
Ying-Ming Tsai, Rösch F, Novgorodov AF, Qaim SM.
Production of the positron-emitting indium isotope 110gIn via the 110Cd(3He,3n)110Sn  110gIn-process.
J Appl Radiat Isot 48 (1997) 19-26
Klein AT, Rösch F, Qaim SM.
Production of the positron emitter 51Mn for in vivo evaluation of 51Mn-labeled MRI contrast agents via PET.
J Label Compd Radiopharm 39 (1997) 501-503
Wester HJ, Brockmann J, Rösch F, Stolz B, Wutz W, Herzog H, Smith-Jones PM, Bruns C, Stöcklin G.
Quantitative in vivo uptake kinetics of 18F-octreotide measured by PET: A comparison with 86Y-DTPA-octreotide and 68Ga-DFO-octreotide in tumor bearing rats.
Nucl Med Biol 24 (1997) 275-286
Brockmann J, Rösch F, Herzog H, Mühlensiepen H, Köhle M, Stolz B, Marbach P, Müller-Gärtner HW.
Complexation, in vivo-stability, blood clearance and excretion kinetics of 86Y-DOTA-Tyr3-octreotide in baboons.
J Label Compd Radiopharm 39 (1997) 468-470
Brockmann J, Rösch F.
Determination of stability constants in Y-DTPA-peptide systems:
Evaluation of a radiochemical method using n.c.a. yttrium-88.
J Label Compd Radiopharm 39 (1997) 471-473
 
 
1996
Rösch F, Herzog H, Plag C, Neumaier B, Braun U, Müller-Gärtner HW, Stöcklin G.
Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission tomography.
Eur J Nucl Med 23 (1996) 958-966
Link EM, Michalowski AS, Rösch F.
211At-Methylene blue for targeted radiotherapy of disseminated melanoma: Microscopic analysis of tumour versus normal tissue damage.
Europ J Cancer 32A (1996) 1986-1996
 
 
1995
Denzler FO , Rösch F, Novgorodov AF, Lebedev NA, Qaim SM.
Excitation functions of α-particle induced nuclear reactions on highly enriched 92Mo: Comparative evaluation of production routes for 94mTc.
Radiochim Acta 68/1/ (1995) 13-20
Qaim SM, Uhl M, Rösch F, Szelec`senyi F.
Excitation functions of (p,α) reactions on 64Ni, 78Kr, and 86Sr.
Phys Rev C 52/2/ (1995) 773-739
Denzler FO, Rösch F, Novgorodov AF, Lebedev NA, Qaim SM.
Excitation functions of α- and 3He-particle induced nuclear reactions on highly enriched 147Sm and 144Sm: Comparative evaluation of production routes for 147Gd.
Radiochim Acta 69 (1995) 209-213
Neumaier B, Rösch F.
Binding of radioyttrium to human serum albumin: Relevance to endotherapeutic applications of 90Y-labelled pharmaceutics.
J Label Compd Radiopharm 37 (1995) 569-570
Brockmann J, Rösch F.
Labelling of small peptides with yttrium and gallium via a new DOTA-derivative or DFO using different disuccinimidylic esters as linker.
J Label Compd Radiopharm 37 (1995) 516-518
Brockmann J, Rösch F, Herzog H, Stolz B, Bruns C, Stöcklin G.
In vivo uptake kinetics and dosimetric calculations of 86Y-DTPA-octreotide with PET as a model for potential endotherapeutic octreotides labeled with 90Y.
J Label Compd Radiopharm 37 (1995) 519-521
Stöcklin G, Qaim SM, Rösch F.
The impact of radioactivity on life sciences.
Radiochim Acta 70/71 (1995) 249-272
 
 
1994
Link EM, Michalowski AS, Rösch F.
211At-Methylene blue in targeted radiotherapy of disseminated melanoma.
Pigment Cell Res 7 (1994) 358-362
Rösch F, Novgorodov AF, Qaim SM.
Thermochromatographic separation of 94mTc from enriched molybdenum targets and its large scale production for nuclear medical application.
Radiochim Acta 64 (1994) 113-120
Neumaier B, Rösch F, Qaim SM, Stöcklin G.
Radiochemical study of the 209Bi(p,7Be)203Hg-process from 20 to 70 MeV via identification of the emitted particle (7Be) and the product nucleus (203Hg).
Radiochim Acta 65 /1/ (1994) 1-7
Rösch F, Novgorodov AF, Qaim SM, Stöcklin G.
High purity production of the positron emitting technetium iotope 94mTc.
J Label Compd Radiopharm 35 (1994) 267-269
Faßbender M, Novgorodov AF, Rösch F, Qaim SM.
Excitation functions of 93Nb(3He,xn)93m,g,94m,g,95m,gTc-processes from threshold up to 35 MeV: Possibility of production of 94mTc in high radiochemical purity using a thermochromatographic separation technique.
Radiochim Acta 65 (1994) 215-221
Rösch F, Neumaier B, Stöcklin G, Qaim SM, Herzog H, Müller-Gärtner HW.
[86Y]Citrate and [86Y]EDTMP: Preparation, chemical characterization and in vivo quantitation of their pharmacological data with PET.
J Label Compd Radiopharm 35 (1994) 546-548
 
 
1993
Rösch F, Qaim SM, Stöcklin G.
New nuclear data relevant to the production of the positron emitting radioisotope 86Y.
J Label Compd Radiopharm 32 (1993) 449-451
Rösch F, Qaim SM, Stöcklin G.
Production of the positron emitting radionuclide 86Y for nuclear medical application.
Int J Appl Radiat Isot 44 /4/ (1993) 677-681
Rösch F, Qaim SM, Stöcklin G.
Nuclear data relevant to the production of the positron emitting radioisotope 86Y via the 86Sr(p,n)- and natRb(3He,xn)-processes.
Radiochim Acta 61 /1/ (1993) 1-8
Rösch F, Qaim SM.
Nuclear Data Relevant to the Production of the Positron Emitting Technetium Isotope 94mTc via the 94Mo(p,n)-reaction.
Radiochim Acta 62 (1993) 115-121
Herzog H, Rösch F, Stöcklin G, Lueders C, Qaim SM,  Feinendegen LE.
Measurement of pharmacokinetics of yttrium-86 radiopharmaceuticals with PET and radiation dose calculation of analogous yttrium-90 radiotherapeutics.
J Nucl Med 34 (1993) 2222-2226
 
 
1992
Beyer GJ, Bergmann R, Kampf G, Mäding P, Rösch F.
Simultaneous study of the biodistribution of radio-yttrium complexed with EDTMP and citrate ligands in tumour-bearing rats.
Nucl Med Biol 19 / 2/ (1992) 201-203
Mäding P, Römer J, Rösch F.
Chemical synthesis of L-[75Se]selenomethionine in a high-activity scale.
Int J Appl Radiat Isot 43 /4/ (1992) 495-501
 
 
1991
Rösch F, Brankoff T, Görner H, Große B, Kasper KH, Kretzschmar C, Mäding P, Mittag E, Noll S, Poser D, Rockstroh K, Römer J, Ryssel G, Schäfer G.
Chemische Synthese von L-[75Se]Selenomethionin für die Routineproduktion.
Report ZfK-737 (1991)
Rösch F, Beyer GJ. Längerlebige Positron-Emitter:
Einzelnuklide und Generatorsysteme, Herstellung am U-120 Zyklotron in Rossendorf, radiochemische Studien sowie Möglichkeiten für die PET.
Report ZfK-771 (1991)
 
 
1990
Novgorodov AF, Rösch F, Szielinski A , Misak R, Kolachkovski, Beyer GJ, Schomäcker K.
Simple thermochromatographic separation of 67Ga from metallic zinc targets.
Isotopenpraxis 26 /4/ (1990) 11-13
Rösch F, Beyer GJ, Anders B, Gurratzsch H, Steinbach J.
Zur Isotopenproduktion am Rossendorfer Zyklotron U-120.
Med.nucl. 2 /1/ (1990) 4-7
Rösch F, Khalkin VA.
Ion mobilities of trivalent f-elements in aqueous electrolytes.
Radiochim Acta 51 /3/ (1990) 101-106
Rösch F, Dittrich S, Buklanov GV, Milanov M, Khalkin VA, Dreyer R.
electromigration of Carrier-Free Radionuclides. 12. Reactions of 239Np(V) with Acetate and Citrate Ligands in Neutral solution.
Radiochim Acta 49 /1/ (1990) 29-34
Rösch F, Reimann T, Buklanov TV, Milanov M, Khalkin VA, Dreyer R.
Electromigration of Carrier-Free Radionuclides. 14. Complex Formation of 241Am-Am(III) with Oxalate and Sulfate in aqueous solution.
J Radioanal Nucl Chem, Articles, 140 /1/ (1990) 159-169
Rösch F, Tran Kim Hung, Dittrich S, Ludwig R, Buklanov GV, Dreyer R, Khalkin VA.
electromigration Studies of Carrier-Free 239Np(V) in aqueous solutions.
Isotopenpraxis 26 /8/ (1990) 355-363
Beyer GJ, Rösch F.
A high-purity 82Sr/82Rb generator.
CERN-EP/90-91
Beyer GJ, Bergmann R, Schomäcker K, Rösch F, Schäfer G, Kulikov EV, Novgorodov AV.
Comparison of the Biodistribution of 225Ac and Radiolanthanides as Citrate Complexes
Isotopenpraxis 26 /3/ (1990) 111-114
 
 
1989
Beyer GJ, Novgorodov AJ, Rösch F, Ravn Hl.
Spallation Produced Radioisotopes for Nuclear Medical Application.
Isotopenpraxis 25 /1/ (1989) 2-10
Rösch F.
Prinzipien der Elektromigrationsmessung: pH-Abhängigkeiten individueller Ionenbeweglichkeiten von Metallkationen.
Report ZfK-664 (1989)
Rösch F, Dreyer R, Khalkin VA, Milanov M, Tran Kim Hung, Doberenz W.
Prinzipien der Elektromigrationsmessung: Der Übergang von inhomogenen Mehrphasensystemen zu homogenen Elektrolyten ohne Zusatz chromatographischer Materialien. Report ZfK-665 (1989)
Rösch F, Dreyer R, Khalkin VA.
Prinzipien der Elektromigrationsmessung: Untersuchungen von Komplexbildungsgleichgewichten.
Report ZfK-677 (1989)
Rösch F, Dreyer R, Khalkin VA.
Prinzipien der Elektromigrationsmessung: Analytik von Protolysegleichgewichten.
Report ZfK-691 (1989)
Rösch F, Reimann T, Buklanov GV, Milanov M, Khalkin VA, Dreyer R.
Electromigration of Carrier-Free Radionuclides. 13. Ion mobilities and Hydrolysis of 241Am(III) in aqueous Inert electrolytes.
J Radioanal Nucl Chem, Articles, 134 /1/ (1989) 109-128
Rösch F, Reimann T,  Buklanov GV, Milanov M, Khalkin VA.
Electromigration of Carrier-Free Radionuclides. 8. Hydrolysis of 249Cf(III) in aqueous solution.
Radiochim Acta 47 /2/ (1989) 187-189
Rösch F, Dittrich S, Buklanov GV, Milanov M, Khalkin VA, Dreyer R.
Electromigration of Carrier-Free Radionuclides. 11. Complex Formation of 239Np(V) with Oxalate, Tartrate and Sulphate in Neutral Inert electrolytes.
Radiochim Acta 48 /2/ (1989) 205-211
Tran Kim Hung, Milanov M, Rösch F, Khalkin VA.
Investigation of Astatine Cation electromigration.
Radiochim Acta 47 /1/ (1989) 105-108
 
 
1988
Rösch F.
Prinzipien der Elektromigrationsmessung: Individuelle Ionenbeweglichkeiten in Reaktionsgleichgewichten in wäßrigen Lösungen.
Report ZfK-651 (1988)
Rösch F.
Prinzipien der Elektromigrationsmessung: Berechnungsmodelle von Stabilitätskonstanten.
Report ZfK-652 (1988)
Rösch F, Dittrich S, Khalkin VA, Dreyer R.
Prinzipien der Elektromigrationsmessung: Mathematische Optimierung von Elektromigrations-Separations-Prozessen.
Report ZfK-653 (1988)
Rösch F, Tran Kim Hung, Milanov M, Khalkin VA.
Electromigration of Carrier-Free Radionuclides. 6. Iodide and Bromide Complexes of Carrier-Free 201Tl(I) in aqueous solutions.
Isotopenpraxis 24 /10/ (1988) 383-386
Rösch F, Tran Kim Hung, Milanov M, Khalkin VA.
Electromigration of Carrier-Free Radionuclides. 7. 201Tl-Thallium(I) Sulphate Complexes in aqueous solutions.
Isotopenpraxis 24 /10/ (1988) 386-388
Rösch F, Tran Kim Hung, Milanov M, Khalkin VA.
Electromigration of Carrier-Free Radionuclides. 9. Protolysis of 131I-Iodate in aqueous solution.
J Chromatogr 457 (1988) 362-365
 
 
1987
Rösch F, Novgorodov AF, Herrmann R, Kolachkovski A, Mikecz P, Szielinski A.
Eine Technologie zur Herstellung von 199Tl über die 197Au(,α,2n)-Reaktion.
Radiobiol Radiotherap 28 /6/ (1987) 827-830
Milanov M, Rösch F, Khalkin VA, Henniger J, Tran Kim Hung.
Elektromigraziya ionov radionuklidov bez nositeley v elektrolitach. Gidroliz Bi(III) v vodnych elektrolytach (russ.).
Radiokhimiya 29 /1/ (1987) 21-29
Rösch F, Tran Kim Hung, Milanov M, Khalkin VA.
Bismuth Complexes in aqueous solutions of Oxalic, Fumaric and Succinic Acids.
Talanta 34 (1987) 375-380
Rösch F, Tran Kim Hung, Milanov M, Khalkin VA.
Electromigration of Carrier-Free Radionuclides. 3. Oxalate and Tartrate Complexes of Ytterbium(III) in aqueous solution
J Chromatogr 396 (1987) 43-50
Rösch F, Herrmann R, Tran Kim Hung, Milanov M, Khalkin VA.
Electromigration of Carrier-Free Radionuclides. 4. Oxalate and Tartrate Complexes of La(III) in aqueous solution.
J Radioanal Nucl Chem 111 /2/ (1987) 319-327
Rösch F, Milanov M, Tran Kim Hung, Ludwig R, Buklanov GV, Khalkin VA.
Electromigration of Carrier-Free Radionuclides. 5. Ion mobilities and hydrolysis of Np(V) in aqueous perchlorate solutions.
Radiochim Acta 42 /1/ (1987) 43-46
Rösch F, Khalkin VA, Milanov M, Tran Kim Hung, Dreyer R.
Elektromigration von -Radionukliden in homogenen wäßrigen Elektrolyten ohne Zusatz stabilisierender Träger
Z Chem 27 /10/ (1987) 358-366
Milanov M, Tran Kim Hung, Shoninski D, Rösch F, Khalkin VA.
Yacheyka dlya gorizontalnovo zonnovo elektroforeza ionov v rastvorach fonovych elektrolitov bez inertnych napolnitele. (russ.).
Radiokhimiya 29 /5/ (1987) 650-655
 
 
1986
Dreyer R, Dreyer I, Doberenz W, Fischer S, Khalkin VA, Rösch F.
Zur anorganischen Chemie des monovalenten Astats.
Isotopenpraxis 22 /3/ (1986) 81-87
Novgorodov AF, Buklanov GV, Szielinzki A, Kolachkovski A, Rösch F, Schomäcker K.
A simple method for the separation of 111In from silver by thermochromatographyInt
J Appl Radiat Isot 37 /5/ (1986) 445-447
Rösch F, Eichler B.
Adsorbtion von Metallen auf metallischen Oberflächen und Möglichkeiten ihrer Nutzung in der Kernchemie. Modellberechnung zur Trennung von Radionukliden durch thermische Desorbtion von festen Metalloberflächen.
Report ZfK-575 (1986)
Rösch F, Eichler B.
Adsorbtion von Metallen auf metallischen Oberflächen und Möglichkeiten ihrer Nutzung in der Kernchemie. Radiochemische (Z/Z+1)- und (Z/Z+2)-Trennungen durch thermische Desorbtion von festen Metalloberflächen.
Report ZfK-606 (1986)
Wunderlich G, Henke E, Rösch F, Franke WG, Dreyer.
Tierexperimentelle Studien zur Biokinetik von Astatid und Astat(I)-Komplexverbindungen.
Radiobiol Radiotherap 27 /4/ (1986) 387-392
 
 
1985
Rösch F, Henniger J, Beyer GJ, Dreyer R.
Optimization of bombardement conditions of the 209Bi(α,2n) cyclotron production of 211At.
J Radioanal Nucl Chem 96 /3/ (1985) 333-342
Dreyer R, Dreyer I, Fischer S, Hartmann H, Rösch F.
Syntheses and characterization of cationic astatine compounds with sulfur-containing ligands stable in aqueous solution
J Radioanal Nucl Chem 96 /3/ (1985) 387-392
 
 
1983
Dreyer R, Dreyer I, Rösch F, Fischer S.
Synthesen und erste Charakterisierung von in wässrigen Lösungen stabilen Verbindungen des At()+ mit Thioharnstoff und Thioharnstoffderivaten.
Z Chem 23 /9/ (1983) 346-347
 
 
1982
Dreyer R, Dreyer I, Rösch F, Beyer GJ.
Studies of polyhalogenide ions of astatine
Radiochem Radioanal Lett 54 /3/ (1982) 165-176
Dreyer R, Dreyer I, Rösch F.
Zum Verhalten des Astatids in Halogenidlösungen
Z Chem 22 /2/ (1982) 54-55
Dreyer R, Rösch F,  Beyer GJ.
Astat - Erforschung eines Unbeständigen
Wissenschaft und Fortschritt 32 (1982) 251-255
Dreyer R, Dreyer I, Pfeiffer M, Rösch F.
Pseudohalogen compounds of astatine. First Syntheses and Characterizations of At-Rhodanide and At-Cyanide Compounds
Radiochem Radioanal Lett 55 /4/ (1982) 207-214
 
 
1981
Beyer GJ, Dreyer R, Odrich H, Rösch F.
Production of 211At at the Rossendorf cyclotron U-120.
Radiochem Radioanal Lett 47 /1-2/ (1981) 63-66